Foamix's acne drug misses main goal in late-stage study

(Reuters) - Foamix Pharmaceuticals Ltd said its experimental acne drug failed to meet one of two main goals in a late-stage study, sending its shares down about 30 percent in premarket trading.

Source: Reuters: Health - March 27, 2017 Category: Consumer Health News Tags: healthNews Source Type: news